Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Chubb
Fish and Richardson
US Army
Federal Trade Commission
Queensland Health
Harvard Business School
Deloitte
UBS
Daiichi Sankyo

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079235

« Back to Dashboard
NDA 079235 describes PRILOCAINE HYDROCHLORIDE, which is a drug marketed by Septodont Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the PRILOCAINE HYDROCHLORIDE profile page.

The generic ingredient in PRILOCAINE HYDROCHLORIDE is epinephrine bitartrate; prilocaine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.

Summary for NDA: 079235

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 079235

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 079235

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PRILOCAINE HYDROCHLORIDE
prilocaine hydrochloride
INJECTABLE;INJECTION 079235 ANDA Septodont Inc. 0362-9014 0362-9014-50 50 CARTRIDGE in 1 CARTON (0362-9014-50) > 1.8 mL in 1 CARTRIDGE
PRILOCAINE HYDROCHLORIDE
prilocaine hydrochloride
INJECTABLE;INJECTION 079235 ANDA Dentsply Pharmaceutical Inc. 66312-630 66312-630-14 50 CARTRIDGE in 1 CARTON (66312-630-14) > 1.8 mL in 1 CARTRIDGE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength4%
Approval Date:Sep 29, 2010TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Queensland Health
Chinese Patent Office
Baxter
Cerilliant
Teva
US Department of Justice
Dow
Daiichi Sankyo
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot